Jason Tregellas
Concepts (313)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 34 | 2024 | 446 | 9.670 |
Why?
| | Brain | 50 | 2025 | 2828 | 6.350 |
Why?
| | Magnetic Resonance Imaging | 66 | 2025 | 3710 | 5.450 |
Why?
| | Brain Mapping | 39 | 2023 | 609 | 4.510 |
Why?
| | Nerve Net | 19 | 2024 | 284 | 4.250 |
Why?
| | Nicotinic Agonists | 9 | 2019 | 130 | 3.140 |
Why?
| | Sensory Gating | 6 | 2024 | 45 | 3.010 |
Why?
| | Nicotine | 10 | 2017 | 338 | 2.870 |
Why?
| | Schizophrenic Psychology | 9 | 2019 | 99 | 2.590 |
Why?
| | Neural Pathways | 12 | 2024 | 318 | 2.440 |
Why?
| | Hippocampus | 13 | 2024 | 903 | 2.300 |
Why?
| | Connectome | 5 | 2024 | 91 | 2.250 |
Why?
| | Obesity | 18 | 2025 | 2966 | 2.010 |
Why?
| | Feeding Behavior | 9 | 2023 | 648 | 1.970 |
Why?
| | Cerebral Cortex | 15 | 2020 | 459 | 1.960 |
Why?
| | Energy Intake | 9 | 2019 | 473 | 1.830 |
Why?
| | Overweight | 7 | 2025 | 554 | 1.810 |
Why?
| | Image Processing, Computer-Assisted | 22 | 2019 | 784 | 1.740 |
Why?
| | Hunger | 7 | 2023 | 43 | 1.700 |
Why?
| | Psychotic Disorders | 4 | 2024 | 166 | 1.600 |
Why?
| | Antipsychotic Agents | 4 | 2024 | 196 | 1.570 |
Why?
| | Attention | 8 | 2016 | 453 | 1.520 |
Why?
| | Epilepsies, Partial | 2 | 2021 | 50 | 1.360 |
Why?
| | Auditory Perception | 5 | 2014 | 118 | 1.310 |
Why?
| | Cues | 7 | 2022 | 334 | 1.270 |
Why?
| | Food | 5 | 2022 | 159 | 1.250 |
Why?
| | Drug Resistant Epilepsy | 2 | 2021 | 102 | 1.250 |
Why?
| | Electroencephalography | 6 | 2024 | 436 | 1.210 |
Why?
| | Evoked Potentials, Auditory | 6 | 2015 | 181 | 1.210 |
Why?
| | Adult | 72 | 2025 | 37595 | 1.150 |
Why?
| | Acoustic Stimulation | 9 | 2016 | 340 | 1.090 |
Why?
| | Appetite Regulation | 5 | 2019 | 30 | 1.090 |
Why?
| | Cognition | 5 | 2024 | 1189 | 1.080 |
Why?
| | Appetite | 9 | 2023 | 68 | 1.060 |
Why?
| | Visual Perception | 7 | 2013 | 169 | 1.050 |
Why?
| | Bipolar Disorder | 3 | 2024 | 270 | 1.050 |
Why?
| | Epilepsy | 2 | 2021 | 334 | 1.010 |
Why?
| | Male | 77 | 2025 | 67308 | 0.990 |
Why?
| | Psychomotor Performance | 6 | 2016 | 324 | 0.980 |
Why?
| | Reward | 7 | 2024 | 257 | 0.970 |
Why?
| | Sex Characteristics | 4 | 2023 | 766 | 0.950 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2015 | 423 | 0.940 |
Why?
| | Cognitive Dysfunction | 3 | 2023 | 383 | 0.940 |
Why?
| | Executive Function | 3 | 2019 | 455 | 0.940 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 5 | 2019 | 99 | 0.920 |
Why?
| | Female | 76 | 2025 | 72703 | 0.910 |
Why?
| | Humans | 98 | 2025 | 136899 | 0.900 |
Why?
| | Prefrontal Cortex | 7 | 2025 | 336 | 0.880 |
Why?
| | Neurons | 6 | 2017 | 1608 | 0.830 |
Why?
| | Neuroimaging | 3 | 2020 | 291 | 0.800 |
Why?
| | Benzylidene Compounds | 3 | 2016 | 20 | 0.790 |
Why?
| | Single-Blind Method | 8 | 2017 | 288 | 0.770 |
Why?
| | Weight Gain | 3 | 2024 | 518 | 0.770 |
Why?
| | Cerebellum | 4 | 2013 | 225 | 0.770 |
Why?
| | Headache | 1 | 2023 | 154 | 0.750 |
Why?
| | Pursuit, Smooth | 5 | 2010 | 19 | 0.740 |
Why?
| | Eating | 4 | 2023 | 380 | 0.720 |
Why?
| | Cross-Over Studies | 9 | 2016 | 561 | 0.700 |
Why?
| | Exercise | 5 | 2025 | 2015 | 0.690 |
Why?
| | Satiation | 4 | 2019 | 24 | 0.690 |
Why?
| | Receptors, Nicotinic | 3 | 2013 | 338 | 0.680 |
Why?
| | Sensation Disorders | 2 | 2013 | 34 | 0.670 |
Why?
| | Electrocorticography | 1 | 2020 | 16 | 0.670 |
Why?
| | Noise | 2 | 2012 | 72 | 0.660 |
Why?
| | Cholinergic Agents | 3 | 2016 | 18 | 0.660 |
Why?
| | Neurovascular Coupling | 1 | 2019 | 8 | 0.650 |
Why?
| | Torticollis | 1 | 2019 | 12 | 0.650 |
Why?
| | Magnetoencephalography | 1 | 2020 | 147 | 0.640 |
Why?
| | Cognition Disorders | 5 | 2019 | 517 | 0.620 |
Why?
| | Middle Aged | 36 | 2025 | 33118 | 0.620 |
Why?
| | Neuropsychological Tests | 11 | 2024 | 1063 | 0.610 |
Why?
| | Pyridines | 3 | 2016 | 504 | 0.600 |
Why?
| | Reaction Time | 8 | 2025 | 432 | 0.590 |
Why?
| | Oxygen | 10 | 2017 | 943 | 0.590 |
Why?
| | Neuronal Plasticity | 1 | 2020 | 291 | 0.560 |
Why?
| | Food Preferences | 2 | 2016 | 116 | 0.550 |
Why?
| | Hemodynamics | 2 | 2019 | 1114 | 0.520 |
Why?
| | Thalamus | 2 | 2009 | 110 | 0.520 |
Why?
| | Antiparkinson Agents | 1 | 2016 | 29 | 0.520 |
Why?
| | Memory, Short-Term | 1 | 2019 | 269 | 0.510 |
Why?
| | Analysis of Variance | 7 | 2017 | 1324 | 0.500 |
Why?
| | Molecular Targeted Therapy | 1 | 2019 | 413 | 0.490 |
Why?
| | Diet, Ketogenic | 1 | 2015 | 37 | 0.480 |
Why?
| | Repetition Priming | 1 | 2015 | 9 | 0.480 |
Why?
| | Parkinson Disease | 2 | 2023 | 495 | 0.470 |
Why?
| | Motor Activity | 2 | 2019 | 722 | 0.470 |
Why?
| | Nutrition Policy | 1 | 2015 | 58 | 0.460 |
Why?
| | Limbic System | 2 | 2015 | 48 | 0.460 |
Why?
| | Clozapine | 1 | 2014 | 20 | 0.440 |
Why?
| | Leptin | 2 | 2012 | 233 | 0.430 |
Why?
| | Young Adult | 18 | 2025 | 13157 | 0.420 |
Why?
| | Endophenotypes | 1 | 2013 | 21 | 0.420 |
Why?
| | Psychotropic Drugs | 1 | 2014 | 72 | 0.420 |
Why?
| | Fingers | 1 | 2013 | 88 | 0.410 |
Why?
| | Semantics | 2 | 2013 | 100 | 0.410 |
Why?
| | Brain Waves | 1 | 2013 | 34 | 0.410 |
Why?
| | Body Mass Index | 6 | 2023 | 2351 | 0.400 |
Why?
| | Behavior Therapy | 1 | 2015 | 262 | 0.390 |
Why?
| | Frontal Lobe | 4 | 2016 | 157 | 0.390 |
Why?
| | Efficiency | 1 | 2012 | 98 | 0.370 |
Why?
| | Psychiatric Status Rating Scales | 4 | 2017 | 555 | 0.360 |
Why?
| | Dronabinol | 1 | 2014 | 219 | 0.360 |
Why?
| | Photic Stimulation | 7 | 2016 | 254 | 0.350 |
Why?
| | Patient Compliance | 1 | 2015 | 586 | 0.350 |
Why?
| | Hallucinations | 1 | 2010 | 31 | 0.340 |
Why?
| | Autistic Disorder | 3 | 2009 | 202 | 0.340 |
Why?
| | Space Perception | 1 | 2010 | 83 | 0.320 |
Why?
| | Reproducibility of Results | 5 | 2024 | 3282 | 0.320 |
Why?
| | Thinking | 2 | 2009 | 67 | 0.310 |
Why?
| | Functional Neuroimaging | 4 | 2019 | 76 | 0.310 |
Why?
| | Functional Laterality | 4 | 2013 | 229 | 0.310 |
Why?
| | Statistics as Topic | 4 | 2017 | 316 | 0.310 |
Why?
| | Urbanization | 1 | 2009 | 29 | 0.300 |
Why?
| | Nutritional Status | 1 | 2011 | 343 | 0.300 |
Why?
| | Body Weight | 1 | 2012 | 973 | 0.290 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2015 | 2066 | 0.290 |
Why?
| | Eye Movements | 2 | 2010 | 67 | 0.280 |
Why?
| | Anorexia Nervosa | 3 | 2014 | 86 | 0.270 |
Why?
| | Hyperphagia | 3 | 2019 | 33 | 0.270 |
Why?
| | Case-Control Studies | 7 | 2017 | 3528 | 0.270 |
Why?
| | Gyrus Cinguli | 5 | 2025 | 96 | 0.250 |
Why?
| | Child | 9 | 2021 | 21896 | 0.250 |
Why?
| | Decision Making | 1 | 2013 | 897 | 0.240 |
Why?
| | Taste | 3 | 2014 | 234 | 0.230 |
Why?
| | Delay Discounting | 1 | 2025 | 23 | 0.230 |
Why?
| | Computer Graphics | 2 | 2015 | 42 | 0.230 |
Why?
| | Social Behavior | 1 | 2006 | 300 | 0.220 |
Why?
| | Ocular Motility Disorders | 1 | 2004 | 27 | 0.210 |
Why?
| | Diet | 3 | 2025 | 1261 | 0.210 |
Why?
| | Animals | 9 | 2019 | 36915 | 0.200 |
Why?
| | Echo-Planar Imaging | 1 | 2002 | 21 | 0.200 |
Why?
| | Adolescent | 10 | 2024 | 21402 | 0.190 |
Why?
| | Child Development Disorders, Pervasive | 2 | 2013 | 62 | 0.190 |
Why?
| | Atrophy | 3 | 2023 | 184 | 0.190 |
Why?
| | Learning | 1 | 2006 | 427 | 0.190 |
Why?
| | Risk | 1 | 2024 | 905 | 0.180 |
Why?
| | Biomarkers | 4 | 2019 | 4148 | 0.180 |
Why?
| | Exercise Therapy | 1 | 2025 | 432 | 0.170 |
Why?
| | Maternal Inheritance | 1 | 2020 | 16 | 0.170 |
Why?
| | Psychometrics | 1 | 2024 | 719 | 0.170 |
Why?
| | Organ Size | 3 | 2012 | 479 | 0.170 |
Why?
| | Fasting | 4 | 2019 | 276 | 0.170 |
Why?
| | Smoking | 2 | 2007 | 1633 | 0.170 |
Why?
| | Weight Loss | 2 | 2019 | 765 | 0.170 |
Why?
| | Rest | 1 | 2020 | 122 | 0.170 |
Why?
| | Neural Inhibition | 2 | 2015 | 173 | 0.160 |
Why?
| | Child Development | 1 | 2024 | 474 | 0.160 |
Why?
| | Parietal Lobe | 2 | 2013 | 60 | 0.160 |
Why?
| | Thinness | 2 | 2011 | 91 | 0.150 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2019 | 70 | 0.150 |
Why?
| | Diet, Reducing | 1 | 2019 | 88 | 0.150 |
Why?
| | Substance-Related Disorders | 3 | 2013 | 1079 | 0.150 |
Why?
| | Drug Users | 2 | 2016 | 41 | 0.150 |
Why?
| | Seizures | 1 | 2021 | 427 | 0.140 |
Why?
| | Absorptiometry, Photon | 2 | 2016 | 251 | 0.140 |
Why?
| | Energy Metabolism | 2 | 2014 | 892 | 0.140 |
Why?
| | Food Analysis | 1 | 2017 | 26 | 0.140 |
Why?
| | Temporal Lobe | 2 | 2020 | 91 | 0.140 |
Why?
| | Longitudinal Studies | 2 | 2023 | 2844 | 0.140 |
Why?
| | Gastric Bypass | 1 | 2019 | 118 | 0.140 |
Why?
| | Surveys and Questionnaires | 5 | 2017 | 5730 | 0.130 |
Why?
| | Mice | 4 | 2015 | 17775 | 0.130 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2019 | 179 | 0.130 |
Why?
| | Tobacco Use Disorder | 1 | 2019 | 252 | 0.130 |
Why?
| | Levodopa | 1 | 2016 | 31 | 0.130 |
Why?
| | Child, Preschool | 3 | 2020 | 11013 | 0.130 |
Why?
| | Maximal Voluntary Ventilation | 1 | 2016 | 8 | 0.130 |
Why?
| | Social Control, Informal | 2 | 2013 | 22 | 0.120 |
Why?
| | Cerebrovascular Circulation | 2 | 2009 | 241 | 0.120 |
Why?
| | Basal Metabolism | 1 | 2016 | 60 | 0.120 |
Why?
| | Mental Disorders | 1 | 2024 | 1080 | 0.120 |
Why?
| | Aversive Therapy | 1 | 2015 | 3 | 0.120 |
Why?
| | Dietary Fiber | 1 | 2016 | 53 | 0.120 |
Why?
| | Lost to Follow-Up | 1 | 2015 | 21 | 0.120 |
Why?
| | Ketones | 1 | 2015 | 51 | 0.120 |
Why?
| | Hormones | 1 | 2016 | 143 | 0.120 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1945 | 0.120 |
Why?
| | Cohort Studies | 3 | 2020 | 5711 | 0.120 |
Why?
| | Autism Spectrum Disorder | 1 | 2020 | 399 | 0.120 |
Why?
| | Choice Behavior | 1 | 2016 | 174 | 0.110 |
Why?
| | Patch-Clamp Techniques | 1 | 2015 | 288 | 0.110 |
Why?
| | Administration, Cutaneous | 1 | 2014 | 128 | 0.110 |
Why?
| | Dietary Proteins | 1 | 2016 | 135 | 0.110 |
Why?
| | Time Factors | 3 | 2015 | 6802 | 0.110 |
Why?
| | Sweetening Agents | 1 | 2014 | 53 | 0.110 |
Why?
| | Treatment Outcome | 2 | 2021 | 10768 | 0.110 |
Why?
| | CA3 Region, Hippocampal | 1 | 2014 | 7 | 0.110 |
Why?
| | Signal-To-Noise Ratio | 1 | 2014 | 71 | 0.110 |
Why?
| | Gamma Rhythm | 1 | 2013 | 6 | 0.110 |
Why?
| | Computer Simulation | 2 | 2019 | 984 | 0.110 |
Why?
| | Mice, Inbred DBA | 1 | 2014 | 196 | 0.110 |
Why?
| | Visual Cortex | 2 | 2005 | 73 | 0.100 |
Why?
| | Regression Analysis | 4 | 2019 | 1026 | 0.100 |
Why?
| | Psycholinguistics | 1 | 2013 | 20 | 0.100 |
Why?
| | Mice, Inbred C3H | 1 | 2013 | 272 | 0.100 |
Why?
| | Symptom Assessment | 1 | 2014 | 126 | 0.100 |
Why?
| | Satiety Response | 1 | 2012 | 9 | 0.100 |
Why?
| | Diabetes, Gestational | 1 | 2017 | 310 | 0.100 |
Why?
| | Heart Rate | 1 | 2017 | 830 | 0.100 |
Why?
| | Drug Discovery | 1 | 2013 | 141 | 0.100 |
Why?
| | Drug Interactions | 1 | 2014 | 409 | 0.100 |
Why?
| | Blood Glucose | 2 | 2019 | 2161 | 0.100 |
Why?
| | Models, Animal | 1 | 2014 | 387 | 0.090 |
Why?
| | Task Performance and Analysis | 1 | 2013 | 182 | 0.090 |
Why?
| | Body Composition | 1 | 2016 | 665 | 0.090 |
Why?
| | Insulin | 2 | 2019 | 2389 | 0.090 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5398 | 0.090 |
Why?
| | Fornix, Brain | 1 | 2011 | 6 | 0.090 |
Why?
| | Health Behavior | 1 | 2017 | 761 | 0.090 |
Why?
| | Aged | 3 | 2019 | 23641 | 0.090 |
Why?
| | Conduct Disorder | 1 | 2013 | 201 | 0.090 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2011 | 47 | 0.090 |
Why?
| | Subliminal Stimulation | 1 | 2010 | 2 | 0.090 |
Why?
| | Sensation | 1 | 2011 | 54 | 0.090 |
Why?
| | Marijuana Abuse | 1 | 2014 | 234 | 0.090 |
Why?
| | Parents | 2 | 2012 | 1361 | 0.090 |
Why?
| | Algorithms | 2 | 2019 | 1695 | 0.090 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 606 | 0.080 |
Why?
| | Speech Perception | 1 | 2012 | 88 | 0.080 |
Why?
| | Exercise Test | 1 | 2013 | 621 | 0.080 |
Why?
| | Infant | 1 | 2024 | 9408 | 0.080 |
Why?
| | Reference Values | 3 | 2008 | 820 | 0.080 |
Why?
| | Pregnancy | 2 | 2020 | 6715 | 0.080 |
Why?
| | Facial Expression | 1 | 2010 | 76 | 0.080 |
Why?
| | Models, Statistical | 1 | 2014 | 667 | 0.080 |
Why?
| | Blood Pressure | 1 | 2017 | 1774 | 0.080 |
Why?
| | Self-Injurious Behavior | 1 | 2011 | 131 | 0.080 |
Why?
| | Colorado | 2 | 2019 | 4491 | 0.080 |
Why?
| | Outpatients | 1 | 2012 | 393 | 0.080 |
Why?
| | Fragile X Syndrome | 1 | 2009 | 84 | 0.080 |
Why?
| | Corpus Striatum | 1 | 2010 | 166 | 0.080 |
Why?
| | Artifacts | 2 | 2007 | 134 | 0.080 |
Why?
| | Arousal | 1 | 2009 | 160 | 0.070 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2182 | 0.070 |
Why?
| | Family | 1 | 2012 | 667 | 0.070 |
Why?
| | Genotype | 2 | 2010 | 1906 | 0.070 |
Why?
| | Dominance, Cerebral | 1 | 2007 | 56 | 0.070 |
Why?
| | Double-Blind Method | 2 | 2009 | 1980 | 0.070 |
Why?
| | Visual Fields | 2 | 2005 | 90 | 0.070 |
Why?
| | Nerve Fibers | 1 | 2007 | 96 | 0.070 |
Why?
| | Communication Disorders | 1 | 2006 | 10 | 0.070 |
Why?
| | Stereotyped Behavior | 1 | 2006 | 19 | 0.070 |
Why?
| | Auditory Cortex | 1 | 2007 | 43 | 0.070 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 2 | 2007 | 243 | 0.070 |
Why?
| | Postprandial Period | 2 | 2019 | 105 | 0.070 |
Why?
| | Aggression | 1 | 2009 | 210 | 0.070 |
Why?
| | Hypothalamus | 1 | 2007 | 153 | 0.070 |
Why?
| | Rats | 1 | 2015 | 5675 | 0.060 |
Why?
| | Intelligence | 1 | 2006 | 131 | 0.060 |
Why?
| | Prospective Studies | 2 | 2017 | 7543 | 0.060 |
Why?
| | Ganglionic Stimulants | 1 | 2005 | 14 | 0.060 |
Why?
| | Judgment | 1 | 2006 | 64 | 0.060 |
Why?
| | National Institute of Mental Health (U.S.) | 1 | 2024 | 5 | 0.060 |
Why?
| | Emotions | 1 | 2010 | 585 | 0.060 |
Why?
| | Disease Models, Animal | 1 | 2015 | 4281 | 0.060 |
Why?
| | Visual Pathways | 1 | 2005 | 56 | 0.060 |
Why?
| | Amygdala | 2 | 2016 | 208 | 0.060 |
Why?
| | Breakfast | 2 | 2016 | 20 | 0.060 |
Why?
| | Area Under Curve | 1 | 2005 | 316 | 0.050 |
Why?
| | Pain | 1 | 2010 | 834 | 0.050 |
Why?
| | Impulsive Behavior | 1 | 2025 | 150 | 0.050 |
Why?
| | Factor Analysis, Statistical | 1 | 2024 | 287 | 0.050 |
Why?
| | Feasibility Studies | 1 | 2007 | 943 | 0.050 |
Why?
| | Head | 1 | 2004 | 108 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2010 | 2175 | 0.050 |
Why?
| | Basal Ganglia | 1 | 2023 | 56 | 0.050 |
Why?
| | Promoter Regions, Genetic | 1 | 2007 | 1255 | 0.050 |
Why?
| | Risk Factors | 2 | 2017 | 10313 | 0.050 |
Why?
| | Retrospective Studies | 1 | 2020 | 15514 | 0.050 |
Why?
| | Movement | 1 | 2004 | 273 | 0.050 |
Why?
| | Insulin Resistance | 2 | 2019 | 1187 | 0.040 |
Why?
| | Interview, Psychological | 2 | 2013 | 98 | 0.040 |
Why?
| | Peptide YY | 1 | 2019 | 17 | 0.040 |
Why?
| | Ghrelin | 1 | 2019 | 36 | 0.040 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2012 | 279 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2019 | 434 | 0.040 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2019 | 127 | 0.040 |
Why?
| | Models, Neurological | 1 | 2019 | 259 | 0.030 |
Why?
| | Lunch | 1 | 2016 | 7 | 0.030 |
Why?
| | Language | 1 | 2019 | 299 | 0.030 |
Why?
| | Homeostasis | 1 | 2019 | 622 | 0.030 |
Why?
| | Taste Perception | 1 | 2014 | 31 | 0.030 |
Why?
| | Machine Learning | 1 | 2019 | 487 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 148 | 0.030 |
Why?
| | Pleasure | 1 | 2013 | 21 | 0.030 |
Why?
| | Mothers | 1 | 2019 | 752 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1279 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2013 | 196 | 0.020 |
Why?
| | Sucrose | 1 | 2012 | 109 | 0.020 |
Why?
| | Conditioning, Operant | 1 | 2012 | 104 | 0.020 |
Why?
| | Anisotropy | 1 | 2011 | 80 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3201 | 0.020 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2011 | 153 | 0.020 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2008 | 9 | 0.020 |
Why?
| | Temperance | 1 | 2008 | 13 | 0.020 |
Why?
| | Amphetamine-Related Disorders | 1 | 2008 | 40 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5126 | 0.020 |
Why?
| | Lod Score | 1 | 2007 | 67 | 0.020 |
Why?
| | Cocaine-Related Disorders | 1 | 2008 | 113 | 0.020 |
Why?
| | United States | 1 | 2024 | 14595 | 0.020 |
Why?
| | Alcohol-Related Disorders | 1 | 2008 | 124 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 2030 | 0.020 |
Why?
| | Chewing Gum | 1 | 2004 | 9 | 0.010 |
Why?
| | Imaging, Three-Dimensional | 1 | 2008 | 578 | 0.010 |
Why?
| | Verbal Behavior | 1 | 2004 | 46 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2005 | 299 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2007 | 652 | 0.010 |
Why?
| | Genetic Markers | 1 | 2005 | 345 | 0.010 |
Why?
| | Early Diagnosis | 1 | 2005 | 243 | 0.010 |
Why?
| | Gene Frequency | 1 | 2005 | 521 | 0.010 |
Why?
| | Administration, Oral | 1 | 2005 | 811 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2416 | 0.010 |
Why?
| | Fourier Analysis | 1 | 2002 | 41 | 0.010 |
Why?
|
|
Tregellas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|